Your ₹6.3 Crore Lesson: NSE's Winners Got Lucky, Not Smart

Run the math backward on NSE's draft IPO papers and one number falls out that nobody is putting in a headline: ₹2,015. Divide the ₹30,000 crore offer size bankers are floating by the 14.89 crore shares actually being sold, and that's roughly what one NSE share is worth right now. Here's the strange part. It's almost exactly what the share is worth whether you bought it in 1993 or in 2019.

New India Assurance is staring at a return near 6,300 times its original outlay. National Insurance has done marginally better, at roughly 6,442 times. Canada Pension Plan Investment Board, which wrote its cheque three decades after the insurers did, walks away with about 6.3 times its money. Those numbers will dominate every headline this week, and they should — a 6,442x return on anything is rare in any market, anywhere.

But the multiple is the wrong number to stare at. The right one is ₹2,015. Almost every shareholder, old or new, is being handed nearly the same rupee figure per share. What separated a 6.3x outcome from a 6,442x one was never strategy, sector insight, or risk appetite. It was the date on the cheque.

The Core Problem

NSE wasn't built to make anyone rich. It was set up in 1992 and began trading in 1993 as a public-utility experiment — a screen-based, dematerialised exchange meant to clean up a broker-run market that had just survived a major scam. To get it off the ground, the founders needed banks, insurers and development institutions to put up capital with no real expectation of a payout. Shares went out near face value of ₹1, later diluted further by decades of bonus issues and stock splits, to institutions including New India Assurance, National Insurance and State Bank of India, who were effectively doing a market-building favour rather than making a calculated bet on what an exchange could one day become.

Think about what these institutions were actually being asked to underwrite. There was no guarantee a screen-based exchange would beat the existing broker-run system, no certainty that retail India would ever trust dematerialised shares over paper certificates, and no way to know that NSE would eventually outgrow every regional exchange in the country combined. The cheque the insurers wrote in the 1990s reads more like development funding than equity research.

That bargain-bin pricing is the entire explanation for today's eye-watering multiples. It has nothing to do with these insurers correctly forecasting that an Indian exchange would one day clear trillions of rupees in daily volume and become a near-monopoly in equity derivatives. They paid a token price for a stake in an unproven utility, and three decades of compounding did the rest.

Canada Pension Plan Investment Board's story runs the other way. By the time it bought in, NSE was already the dominant exchange in the world's most-traded derivatives market, throwing off the kind of cash flow institutional investors fight over. CPPIB paid for that certainty — roughly ₹324 a share, by market estimates in NSE's draft prospectus — which is why its return looks ordinary next to the insurers' even though the rupee value per share it's being offered is nearly identical. Your real takeaway shouldn't be that CPPIB invested poorly. It's that the insurers' windfall was never about insurance expertise. It was about being asked to help first, when nobody else wanted in.

There's an awkward footnote here too. NSE's own FY26 numbers, disclosed in the same draft prospectus, show revenue falling 3.1 percent to ₹16,601 crore and profit falling 15.5 percent to ₹10,302 crore, largely on softer transaction and clearing income. The windfall every early shareholder is collecting has nothing to do with how the business performed this year. It was locked in decades ago.

The Data Under the Hood

Line up the entry price, the multiple and the implied exit price for each disclosed seller, and the pattern stops looking like a coincidence.

Five wildly different multiples. One nearly identical exit price across all of them. That's arithmetic, not luck twice over. NSE's offer-for-sale block is fixed at 14.89 crore shares — close to one-sixteenth of the exchange's paid-up equity — and bankers are pricing that block off a deal size near ₹30,000 crore, which is where the ₹2,015-a-share number comes from in the first place.

Notice something else in that table: SBI isn't the biggest multiple, but at 2.48 crore shares sold, it's on track for the single largest cheque of any seller — somewhere close to ₹5,000 crore. Five government-owned entities together are offering roughly 2.37 crore shares into this OFS. The insurers win the headline-multiple contest. SBI wins the actual money.

Personal Calculator

None of this was available to you or me. Retail investors couldn't buy NSE shares in 1993 — the stock has spent its entire life in the unlisted market, traded informally between institutions and a handful of wealthy individuals. But running your own numbers through the same formula is still useful, because it shows you exactly what three decades of being early is worth.

Imagine you'd managed to put ₹10,000 into NSE shares back then, at a price close to what the insurers paid. At ₹0.32 a share, that buys you roughly 31,250 shares. At today's implied exit price of ₹2,015, that stake is worth approximately ₹6.3 crore.

Now compare that to what's actually available to you once NSE lists:

• A retail investor buying in at the IPO price of roughly ₹2,015 a share would need the stock to rally another 6,300x — to about ₹1.27 crore a share — just to match the insurers' outcome. That isn't happening in any of our lifetimes.
• A ₹10,000 monthly SIP into NSE shares after listing, even compounding at a healthy market-beating rate for 20–30 years, lands nowhere near crores territory, because you'd be buying a finished, profitable monopoly at the valuation it has already earned — not the one it might earn.

The lesson isn't that you missed a trade. It's that the trade you missed wasn't actually available to you. Institutional capital was invited in to bootstrap a risky public utility. Retail capital is being invited in three decades later, to buy what that utility became.

Hidden Winners

The insurers, SBI and CPPIB are the obvious names in this story. The less obvious winners are sitting one layer below them.

• BSE: because a stock exchange cannot list itself on its own platform, NSE's shares will trade on BSE instead once listed. Every rupee of listing-day volume and every brokerage transaction tied to the IPO runs through a direct competitor's infrastructure and fee structure.
• LIC: NSE's largest shareholder, holding roughly one-tenth of the company, along with Premji Invest and veteran investor Radhakishan Damani, has chosen not to sell into this offer at all. That's a signal worth more than any quote — these holders are betting the post-listing valuation still understates where NSE is headed, even after this windfall gets booked by everyone else.
• Demat and brokerage platforms: a deal of this size, potentially India's largest-ever public offering, drags in a wave of fresh demat accounts and KYC activity, most of which existing retail brokers will quietly monetise through account charges and trading fees long after listing-day excitement fades.
• Every existing NSE trader: once NSE answers to public shareholders instead of member-institutions, transaction charges and data fees become a lever for profit growth rather than a cost the exchange tries to minimise. If you trade on NSE today, that incentive shift shows up eventually in your own brokerage statement — a quiet, ongoing cost that never makes it into any IPO headline.

What Changes Now

NSE filed its draft red herring prospectus with SEBI this week after receiving the regulator's no-objection certificate, but the filing itself settles very little. SEBI still has to review the document, possibly seek clarifications, and issue its observations before NSE can file the final prospectus and announce a price band and subscription dates. None of that has happened yet.

The scale on the table is already large enough to matter beyond this one set of shareholders. At a deal size near ₹30,000 crore, this offer could become India's biggest public issue on record, ahead of Hyundai Motor India's ₹27,870 crore offering. That size alone pulls in fresh demat accounts, index-fund flows once NSE eventually qualifies for benchmark inclusion, and a fresh round of scrutiny on exchange fees from a regulator that has spent years tightening derivatives trading norms.

That gap matters more than it looks. Every shift in the final deal size moves the implied per-share price, and therefore every multiple in this story, in lockstep. A smaller offer compresses CPPIB's 6.3x back toward 5x while the insurers stay locked somewhere above 6,000x. A larger one pushes every number in this piece up together. Either way, the distance between the smallest and largest multiple stays roughly proportional — because it was never about which investor is smarter. It was set in 1993 and in 2019, long before this week's filing.

The One Number to Watch

Watch the final price band SEBI clears for NSE's offer for sale — specifically, whether the per-share price lands above or below ₹2,015. If it settles below that mark, CPPIB's return compresses toward 5x while the insurers' multiples barely move, confirming this entire windfall is an entry-price story rather than a performance one. If it clears meaningfully above ₹2,015, every multiple in this piece rises together, proving the same point from the other direction.

Frequently Asked Questions

Why are New India Assurance and National Insurance getting thousands of times their money, while CPPIB gets only about 6 times?

It comes down to entry price, not investment skill. The insurers bought NSE shares around ₹0.32 a share in the exchange's early years; CPPIB bought in decades later at roughly ₹324 a share, once NSE was an established, profitable business. Both are being offered close to the same ₹2,015 exit price — the multiple just looks wildly different because the starting point did.

Can retail investors buy NSE shares at the same cheap price the insurers got?

No. NSE has stayed unlisted its entire life, and those early allotments went only to institutions helping bootstrap the exchange in the 1990s. Once NSE lists, retail investors will pay the prevailing market price — currently implied near ₹2,015 a share — which already reflects three decades of growth, not the original near-zero cost.

The views expressed here are for informational purposes and do not constitute personalized financial guidance. Readers should consult a licensed advisor before making investment decisions.